[["widespread thyroid hormone actions", "offer", "the possibility of developing selective thyromimetic analogs"], ["diiodothyropropionic acid (DITPA)", "was studied", "in a prospective, controlled, double-blind 24-wk trial"], ["the trial", "was primarily designed to assess", "treatment of stable chronic heart failure"], ["eighty-six patients", "were randomized", "to placebo or escalating DITPA dose"], ["the DITPA dose", "ranged from", "90 to 360 mg/d"], ["patients", "were studied", "at 2, 4, 6, 8, 16, and 24 wk"], ["only 21 DITPA-treated and 27 placebo patients", "completed", "the full 24 wk of therapy"], ["DITPA therapy", "lowered", "serum TSH levels"], ["serum T(3) and T(4)", "were lowered", "to a lesser extent"], ["there were no differences", "in", "clinical manifestations of thyrotoxicosis or hypothyroidism"], ["serum total and low-density lipoprotein cholesterol levels", "decreased", "on DITPA"], ["there was a transient decrease", "in", "triglycerides"], ["there was no change", "in", "high-density lipoprotein cholesterol"], ["DITPA therapy", "was associated with", "significant reduction in body weight"], ["body weight", "decreased by", "12.5 lb at 24 wk"], ["increases in serum osteocalcin, N-telopeptide, and deoxypyridinoline levels", "were consistent with", "increased bone turnover on DITPA"], ["this investigation of DITPA actions", "demonstrated", "its efficacy in reducing body weight and lowering total and low-density lipoprotein cholesterol levels"], ["DITPA", "resulted in", "a high dropout rate"], ["potentially dangerous skeletal actions", "were observed", "at doses used"]]